The Effect of Vitamin E Supplementation on Hospital Stay Duration in Non-cyanotic Heart Disease Children With Lower Respiratory Tract Infections

Launched by ASSIUT UNIVERSITY · Apr 11, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at whether taking vitamin E can help reduce the time children with certain heart conditions spend in the hospital when they have serious lung infections. These infections can be a big problem for kids with non-cyanotic congenital heart disease, which is a type of heart defect that doesn’t cause a lack of oxygen in the blood. The researchers want to see if vitamin E, known for boosting the immune system, can help these children recover faster and stay healthier.

To be part of the trial, children must be aged between 2 months and 5 years and have a diagnosis of non-cyanotic heart disease along with a severe lung infection. However, kids with other serious health issues, like chronic lung diseases or those who have recently taken vitamin E, won’t be included. The trial is not yet recruiting participants, but it aims to provide valuable information about how vitamin E might improve care for these young patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Pediatric patients are diagnosed with non-cyanotic heart disease associated with severe lower respiratory tract infection. ⁃ The patients are aged 2 months to 5 years of both sexes.
• Exclusion Criteria:
• • Pediatric patients that have other congenital anomalies other than CHD.
• • Those with chronic respiratory diseases such as asthma, bronchiectasis, etc.).
• • Immunocompromised patients, such as those who receive steroids or chemotherapy, etc.
• • Pediatric patient that received vitamin E in the previous month.